Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2024
XYS-NEURO PEDIATRIE from Rixensart, company number BE0886107272, closed financial year 2024 with a result of € -27,221 after tax. For that financial year XYS-NEURO PEDIATRIE recorded a gross margin of € 38,183 and equity of € 128,742. Compared with financial year 2023, the result moved from € 80,796 to € -27,221. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2025.
€ 128,742
▼ 17% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -27,221
▼ still € 80,796 profit in 2023
Profit after tax over the fiscal year.
€ 28,383
▼ 64% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 116,342.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 92,315
▼ 38% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 42,924
▼ 29% vs 2023
€ 16,920 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 4,434
▲ € 4,381 vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 50,580
▼ 34% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 342 | € 91,052 | € 177,968 | € 38,183 | ▼ 79% |
| Profit after taxes | € -3,928 | € 57,275 | € 80,796 | € -27,221 | ▼ € 108,018 |
| Equity | € 17,892 | € 75,167 | € 155,963 | € 128,742 | ▼ 17% |
| Total debts | € 9,700 | € 100,342 | € 190,966 | € 121,214 | ▼ 37% |
| Cash | € 6,705 | € 29,967 | € 78,605 | € 28,383 | ▼ 64% |
| Retained profit | € 5,492 | € 62,767 | € 143,563 | € 116,342 | ▼ 19% |
| Bank debt | € 0 | € 79,495 | € 60,248 | € 42,924 | ▼ 29% |
| Balance sheet total | € 27,591 | € 175,508 | € 346,929 | € 249,955 | ▼ 28% |
Key figures of XYS-NEURO PEDIATRIE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to XYS-NEURO PEDIATRIE?
What happened at XYS-NEURO PEDIATRIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 27,221 (▼ € 108,018 vs 2023). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Rixensart. KBO
- XAVIER SCHLOGEL became a director. NBB
In short
From € 3,928 loss in 2021 to € 27,221 loss in 2024.
Paid € 64,571 in corporate taxes since 2021.
Best year ever: 2023, with € 80,796 profit.
Management
Behind XYS-NEURO PEDIATRIE is XAVIER SCHLOGEL.
Directors
According to the 2024 annual accounts
XAVIER SCHLOGEL
Director
since 2006
Establishments
Establishment units
Physical locations of this company
Avenue Paul Terlinden 2 box 2
1330 Rixensart
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0886.107.272
- VAT number
- BE 0886.107.272
- Registered office
- Avenue Paul Terlinden 2 bus 2, 1330 Rixensart
- Names & denominations
- XYS-NEURO PEDIATRIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 January 2007
- Peppol
- Not registered